Open Access
CC BY-NC-ND 4.0 · Endosc Int Open 2019; 07(12): E1640-E1645
DOI: 10.1055/a-0957-3067
Original article
Owner and Copyright © Georg Thieme Verlag KG 2019

Gastric mucosal devitalization (GMD): translation to a novel endoscopic metabolic therapy

Lea Fayad
1   Johns Hopkins Medical Institutions, Baltimore, Maryland, United States
,
Andreas Oberbach
1   Johns Hopkins Medical Institutions, Baltimore, Maryland, United States
2   Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany
,
Michael Schweitzer
1   Johns Hopkins Medical Institutions, Baltimore, Maryland, United States
,
Frederic Askin
1   Johns Hopkins Medical Institutions, Baltimore, Maryland, United States
,
Lysandra Voltaggio
1   Johns Hopkins Medical Institutions, Baltimore, Maryland, United States
,
Tatianna Larman
1   Johns Hopkins Medical Institutions, Baltimore, Maryland, United States
,
Markus Enderle
3   Erbe GmbH, Tübingen, Germany
,
Hartmut Hahn
3   Erbe GmbH, Tübingen, Germany
,
Mouen A. Khashab
1   Johns Hopkins Medical Institutions, Baltimore, Maryland, United States
,
Anthony N. Kalloo
1   Johns Hopkins Medical Institutions, Baltimore, Maryland, United States
,
Vivek Kumbhari
1   Johns Hopkins Medical Institutions, Baltimore, Maryland, United States
› Author Affiliations
TRIAL REGISTRATION: Single arm, interventional clinical trial NCT03526263 at clinicaltrials.gov
Further Information

Publication History

submitted 14 May 2019

accepted after revision 27 May 2019

Publication Date:
25 November 2019 (online)

Preview

Abstract

Background and study aims The metabolic effects of bariatric surgery may partially result from removal of the gastric mucosa, an often underappreciated endocrine organ. Using argon plasma coagulation (APC), we may be able to selectively devitalize (ablate) the mucosa. The aim of this study was to identify the optimal tissue color that would correspond to selective gastric mucosal devitalization (GMD) using ex-vivo human stomach specimens.

Patients and methods Stomach specimens were obtained at sleeve gastrectomy. Prior to APC application, a submucosal fluid cushion was created. APC was then applied over a 2 × 2-cm area to the fundus and body, aiming for the three indicator colors (white, golden, brown). Pathological analysis was then performed independently and in a blinded fashion by two pathologists to determine the depth of mucosal and submucosal percent thermal injury and mucosal percent cell death.

Results Six patients were enrolled. There was a significant correlation between tissue color and mucosal percent thermal injury. The highest percent mucosal thermal injury was seen with brown (99.6 %, 95 % CI: 98.7, 100), followed by golden (92.5 %, 95 % CI: 85.5, 99.5), and then white (75.2 %, 95 % CI: 58.3, 92.1, P < 0.01). Submucosal thermal injury was seen in 88.9 % of the slides. Greater than minimal submucosal injury (> 10 % depth) was found significantly more with brown tissue color (91.6 %) than golden (75 %) or white (33.3 %, P < 0.05). However, 91.7 % of the entire sample set < 50 % injury.

Conclusion GMD is achievable using APC without thermal injury to muscularis propria. A golden color results in sufficient mucosal injury with only superficial injury to the submucosa.